VENOUS THROMBOSIS

Type: Keyphrase
Name: VENOUS THROMBOSIS
First reported Jul 30 2014 - Updated Jul 30 2014 - 1 reports

Bluegrass Vascular Technologies Raises $4.5M Series A Financing Led By Targeted Technology Funds

SAN ANTONIO"The Surfacer System addresses a significant unmet clinical need in the vascular access market by allowing physicians to gain access through a previously occluded vein," stated Alan DeanThe Targeted Technology Fund is a venture capital firm ... [Published Bio-Medicine - Jul 30 2014]
First reported Jul 30 2014 - Updated Jul 30 2014 - 1 reports

Bluegrass Vascular scores $4.5 mln Series A

Bluegrass Vascular Technologies said Wednesday that it has raised $4.5 million in Series A financing. Targeted Technology Fund II led the round. Based in Lexington, Kentucky, Bluegrass Vascular is a medical tech firm focused on developing methods ... [Published PE Hub Blog - Jul 30 2014]
First reported Jul 27 2014 - Updated Jul 27 2014 - 2 reports

New mercury detectionsystem devised

Device to prevent DVT made in IranScience & Technology DeskResearchers at Tehran’s Amirkabir University of Technology have produced electrical stimulation device to inhibit deep vein thrombosis (DVT) and varicose veins.Venous thrombosis is associated ... [Published Iran Daily - Jul 27 2014]
First reported Jul 24 2014 - Updated Jul 24 2014 - 1 reports

The mTORC Pathway in the Antiphospholipid Syndrome

This article has no abstract; the first 100 words appear below. The antiphospholipid syndrome is an acquired autoimmune disorder characterized by thrombotic events, miscarriages, and elevated levels of antiphospholipid antibodies.1 The syndrome is described ... [Published DailyMe.Com - Jul 24 2014]
First reported Jul 22 2014 - Updated Jul 22 2014 - 1 reports

Risk Factors Associated With Retinal Vein Occlusion

Squizzato A, Manfredi E, Bozzato S, Dentali F, Ageno W. Antithrombotic and fibrinolytic drugs for retinal vein occlusion: a systematic review and a call for action. Thromb Haemost 2010; 103: 271–6.Karia N. Retinal vein occlusion: pathophysiology and treatment ... [Published Theheart.org - Jul 22 2014]
First reported Jul 17 2014 - Updated Jul 17 2014 - 1 reports

Deep Venous Thrombosis: The “Economy Class Syndrome”

US Pharm . 2014;39(7):39-42.ABSTRACT: Deep venous thrombosis (DVT) can be precipitated by prolonged sitting during air travel. As the number of passengers traveling on long-haul flights continues to increase, so does the incidence of DVT. Various measures ... [Published U.S.Pharmacist - Jul 17 2014]
First reported Jul 17 2014 - Updated Jul 17 2014 - 1 reports

Glucose control complicates therapy for UC patients with type 1 diabetes

Treating ulcerative colitis in patients with type 1 diabetes presents numerous challenges as commonly prescribed corticosteroids can affect glucose control, and the diseases share other comorbidities.Researchers surveyed existing studies and discussed ... [Published Orthopedics Today - Jul 17 2014]
First reported Jul 07 2014 - Updated Jul 07 2014 - 2 reports

Payment and Delivery Reform Case Study: Cancer Care

Editor’s note: This post is adapted from a forthcoming full-length case study; the second in a series from the Engelberg Center’s Merkin Initiative on Physician Payment Reform and Clinical Leadership designed to support clinician leadership of health ... [Published Brookings Institution - Jul 07 2014]
First reported Jul 04 2014 - Updated Jul 04 2014 - 1 reports

First Data on Rivaroxaban for Cerebral Venous Thrombosis

Preliminary data suggest that the oral factor Xa inhibitor rivaroxaban ( Xarelto , Bayer Pharma/Janssen Pharmaceuticals) may have similar clinical benefit as vitamin K antagonists in the treatment of cerebral venous thrombosis."Our study has a retrospective, ... [Published General Medicine eJournal - Jul 04 2014]
First reported Jul 01 2014 - Updated Jul 01 2014 - 1 reports

D-Dimer: Not Just an Indicator of Venous Thrombosis but a Predictor of Asymptomatic Hematogenous Metastasis in Gastric Cancer Patients

by Dongmei Diao, Zhe Wang, Yao Cheng, Hao Zhang, Qi Guo, Yongchun Song, Kun Zhu, Kang Li, Di Liu, Chengxue DangBackgroundPlasma D-dimer levels have been shown to be high in advanced tumor stage patients and can be used to predict clinical outcome in cancer ... [Published Plosone.org - Jul 01 2014]
First reported Jun 23 2014 - Updated Jun 23 2014 - 1 reports

Brat scrutiny

einoJune 23, 2014 5:40AM"Hillary fainted while she was working in her seventh-floor office at the State Department, and not at home ... as soon as Bill appeared on the scene and was able to assess Hillary’s condition for himself, he ordered that she be ... [Published Wooster Daily Record - Jun 23 2014]
First reported May 22 2014 - Updated May 22 2014 - 1 reports

Isis Pharmaceuticals Reports Positive Phase 2 Data for ISIS-FXI Rx in the Prevention of Venous Thrombosis in Patients Undergoing Total Knee Replacement Surgery

CARLSBAD, Calif., May 22, 2014 /PRNewswire/ -- Isis Pharmaceuticals, Inc. (NASDAQ: ISIS) announced today positive top-line data from a Phase 2 comparator-controlled study evaluating the incidence of venous thrombolic events (VTE) in patients treated ... [Published PR Newswire: Health - May 22 2014]

Quotes

"The Surfacer System addresses a significant unmet clinical need in the vascular access market by allowing physicians to gain access through a previously occluded vein" stated Alan Dean
...through a previously occluded vein," stated Alan Dean, Senior Managing Director of Targeted Technology Fund II, and Bluegrass Vascular Director. "With a growing market awareness of central venous occlusion and interest in maintaining access, we believe Bluegrass Vascular is well positioned to have a strong presence in the dialysis and chemotherapy markets and is a valued addition to our investment portfolio."
News editors obtained the following quote from the background information supplied by the inventors: "Embodiments of the invention generally relate to methods and apparatus for increasing blood flow and/or adjusting and maintaining the core temperature of a human."

More Content

All (36) | News (31) | Reports (0) | Blogs (5) | Audio/Video (0) | Fact Sheets (0) | Press Releases (0)
sort by: Date | Relevance
Bluegrass Vascular scores $4.5 mln Series A [Published PE Hub Blog - Jul 30 2014]
Bluegrass Vascular Technologies Raises $4.5M Se... [Published Bio-Medicine - Jul 30 2014]
Bluegrass Vascular Technologies Raises $4.5M Se... [Published BusinessWeek - Jul 30 2014]
New mercury detectionsystem devised [Published Iran Daily - Jul 27 2014]
New world record for electrical current [Published Iran Daily - Jul 27 2014]
The mTORC Pathway in the Antiphospholipid Syndrome [Published DailyMe.Com - Jul 24 2014]
Multi-Tissue Omics Analyses Reveal Molecular Re... [Published Plosone.org - Jul 22 2014]
Risk Factors Associated With Retinal Vein Occlu... [Published Theheart.org - Jul 22 2014]
Deep Venous Thrombosis: The “Economy Class Synd... [Published U.S.Pharmacist - Jul 17 2014]
Glucose control complicates therapy for UC pati... [Published Orthopedics Today - Jul 17 2014]
Patent Issued for Methods and Apparatus for Enh... [Published 4 Traders - Jul 17 2014]
Safe insertion of PICC protocol to minimize com... [Published IVTEAM - Jul 12 2014]
A New FDA-Approved Treatment Option for Hot Fla... [Published General Medicine eJournal - Jul 09 2014]
Payment and Delivery Reform Case Study: Cancer ... [Published Brookings Institution - Jul 07 2014]
Payment and Delivery Reform Case Study: Cancer ... [Published Brookings Latest From Brookings - Jul 07 2014]
First Data on Rivaroxaban for Cerebral Venous T... [Published General Medicine eJournal - Jul 04 2014]
D-Dimer: Not Just an Indicator of Venous Thromb... [Published Plosone.org - Jul 01 2014]
Organon Required to Fund $100 Million Dollar Nu... [Published Myrtle Beach Sun News - Jul 01 2014]
Cost effectiveness of different central venous ... [Published IVTEAM - Jun 28 2014]
sodium chloride, potassium chloride, sodium lac... [Published MedicineNet.com - Jun 27 2014]
Patent Issued for Method and Device for Enhance... [Published HispanicBusiness.com - Jun 26 2014]
Hillary faces questions about wealth and health [Published ProKerala.com - Jun 24 2014]
The Obamas vs. the Clintons -- Really? [Published RushLimbaugh.com - Jun 23 2014]
Regado’s Anticoagulation System Suppresses Thro... [Published Drug Discovery and Development - Jun 23 2014]
Hillary ‘hiding worrying health info’ [Published Brisbane Courier-Mail - Jun 23 2014]
Regado Biosciences' REG2 Demonstrates Dose and ... [Published Industrial Info Financials - Jun 23 2014]
Brat scrutiny [Published Wooster Daily Record - Jun 23 2014]
Why the Japanese live so long... and how you ca... [Published Body And Soul - Jun 23 2014]
Momenta Pharmaceuticals Receives Orphan Drug De... [Published GlobeNewswire - Jun 05 2014]
Isis Pharmaceuticals Reports Positive Phase 2 D... [Published PR Newswire: Health - May 22 2014]
1 2
In Focus
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
Bluegrass Vascular scores $4.5 mln Series A [Published PE Hub Blog - Jul 30 2014]
Bluegrass Vascular Technologies said Wednesday that it has raised $4.5 million in Series A financing. Targeted Technology Fund II led the round. Based in Lexington, Kentucky, Bluegrass Vascular is a medical tech firm focused on developing methods ...
Payment and Delivery Reform Case Study: Cancer ... [Published Brookings Latest From Brookings - Jul 07 2014]
Editor’s note: This post is adapted from a forthcoming full-length case study; the second in a series from the Engelberg Center’s Merkin Initiative on Physician Payment Reform and Clinical Leadership designed to support clinician leadership of health ...
Isis Pharmaceuticals Reports Positive Phase 2 D... [Published PR Newswire: Health - May 22 2014]
CARLSBAD, Calif., May 22, 2014 /PRNewswire/ -- Isis Pharmaceuticals, Inc. (NASDAQ: ISIS) announced today positive top-line data from a Phase 2 comparator-controlled study evaluating the incidence of venous thrombolic events (VTE) in patients treated ...
GMO Vaccine-Strain Measles vs Cancer [erv] [Published ScienceBlogs : Combined Feed - May 16 2014]
So scientists cured a woman of a pervasive, treatment resistant  multiple myeloma . With a genetically modified, vaccine strain measles virus. Remission of Disseminated Cancer After Systemic Oncolytic Virotherapy *anti-vax-anti-GMOers-heads-explode* ...
Affinity Biologicals Inc. Now Offers a Complete... [Published PR.com Press Releases - Mar 26 2014]
Ancaster, Canada, March 26, 2014 --( PR.com )-- For the last 25 years, Affinity Biologicals is renowned worldwide for its scientific range of products used in thrombosis and hemostasis research and diagnostics. The company is also known for producing ...
1
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.